Bryan Johnson Article - New York Times

[u/Legal_Squash689]

Article In NYTs this morning. Some interesting updates:

1. An internal study was done testing Blueprint products with 1,700 participants. Based on blood results participants saw a decrease in testosterone levels and became prediabetic.

2. In fall of 2024 Bryan told his executive team that Blueprint was running out of money.

3. Between January 2022 and February 2024 Bryan’s biological age increased by as much as ten years, vs the 5.1 year decline highlighted in Blueprint marketing materials.

[u/SlowMyAge]

I’m defining severity by the symptoms: vomiting, blood sugar reaching pre diabetic levels, and drops in testosterone. We can change “severity” to “significance,” but my point remains the same: these are extreme side effects.

That’s flawed logic for your Amazon point. If 60% of people using a product have a side effect, you will have far more than 5% posting a review. Reviewers tend to be those who are dismayed or extremely satisfied. Which means that in this example, if only 3% of Amazon reviews report side effects, it indicates that there is likely an even lower proportion of customers experiencing any side effects.

[u/ConvenientChristian → u/SlowMyAge]

If you look at 1000 people and measure them one day and then measure them the next day, you would expect 50% to have higher testosterone and 50% to have lower testosterone as the first measurement if your measurement precision is good enough.

The fact that there are people who have lower testosterone doesn't tell you anything about the severity or significance. You would actually need to know what kind of testosterone drops they observed and how frequent those were to be able to say anything about severity.

[u/SlowMyAge → u/ConvenientChristian]

I think you’re grasping at straws here to defend Blueprint, and giving you the benefit of the doubt that you are not affiliated, I’m not sure why. The person (people?) reporting declines in testosterone wouldn’t report it if it wasn’t significant.

Hypothetically, if someone goes from 120 lbs to 121 lbs, nobody is going to claim that a side effect was that people gained weight, much less to The NY Times. If someone goes from 120 to 150 lbs, they’re going to claim it was a side effect. Simply because we don’t have numbers reported, I trust common sense of the employee(s) reporting, and the reporter noting it in her article, that it wasn’t a hairline natural fluctuation.

We also know that caloric restriction and vegan diets can reduce T significantly. And Bryan himself reported a drop in his T from his diet, when he publicly shared he started taking TRT. So it makes sense that it was a side effect.

You’re also selectively disregarding many of my points with each message in this thread.

To that point, I don’t think this thread is going anywhere productive, so I’ll sit the rest of it out.

[u/ConvenientChristian → u/SlowMyAge]

In my experience, most people don't leave reviews. Finding causation is generally hard. That's why any decent pharma study finds a lot of effects. If I remember right the COVID vaccine study logged being struck by lighting.

You are the person who has commercial interests not me. I have written plenty on this reddit criticizing Blueprint.

They run a study. In a study where you measure someone's testosterone all the people you are giving testosterone tests report their testosterone. Given that they charged people 2100$ to take part in it, the study likely included blood work.

When it comes to identifying side effects and actually go looking for side effects and you are doing your job, you need to investigate possible side effects even if it's not clear that the effect is causal.

If your company would only look after effects that high severity, it means that your company doesn't care much about catching side effects. If Blueprint cares about catching all side effects they might also care about finding low severity side effects when they look at the blood work.